ASXC - Asensus Surgical, Inc. Stock Price, Fair Value and News

$0.35

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

ASXC Price Action

Last 7 days

-3.2%

Last 30 days

-11.8%

Last 90 days

15.4%

Trailing 12 Months

6.8%

ASXC RSI Chart

ASXC Valuation

Market Cap

95.5M

Price/Earnings (Trailing)

-1.14

Price/Sales (Trailing)

9.69

EV/EBITDA

-1.09

Price/Free Cashflow

-1.67

ASXC Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ASXC Fundamentals

ASXC Revenue

Revenue (TTM)

9.8M

Rev. Growth (Yr)

104.16%

Rev. Growth (Qtr)

96.53%

ASXC Earnings

Earnings (TTM)

-83.8M

Earnings Growth (Yr)

-24.62%

Earnings Growth (Qtr)

-14.46%

ASXC Profitability

Operating Margin

19.31%

EBT Margin

-847.14%

Return on Equity

739.82%

Return on Assets

-217.65%

Free Cashflow Yield

-59.85%

ASXC Investor Care

Shares Dilution (1Y)

3.40%

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	8.7M	9.8M	0	0
2023	7.0M	7.1M	5.6M	8.6M
2022	7.2M	7.1M	7.1M	7.1M
2021	4.7M	5.1M	6.9M	8.2M
2020	7.0M	4.0M	2.8M	3.2M
2019	21.5M	18.8M	15.4M	8.5M
2018	9.9M	14.7M	20.0M	24.1M
2017	3.6M	5.0M	3.8M	7.1M
2016	0	0	1.8M	1.7M
2014	1.2M	787.0K	486.0K	401.0K
2013	2.0M	1.8M	1.6M	1.4M
2012	0	0	0	2.1M
2010	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

About Asensus Surgical, Inc.

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures. Its products also comprise instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is headquartered in Durham, North Carolina.

CEO	Mr. Anthony Fernando
WEBSITE	asensus.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	183

Asensus Surgical, Inc. Frequently Asked Questions

What is the ticker symbol for Asensus Surgical, Inc.? What does ASXC stand for in stocks?

ASXC is the stock ticker symbol of Asensus Surgical, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Asensus Surgical, Inc. (ASXC)?

As of Thu Aug 22 2024, market cap of Asensus Surgical, Inc. is 95.49 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ASXC stock?

You can check ASXC's fair value in chart for subscribers.

Is Asensus Surgical, Inc. a good stock to buy?

The fair value guage provides a quick view whether ASXC is over valued or under valued. Whether Asensus Surgical, Inc. is cheap or expensive depends on the assumptions which impact Asensus Surgical, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ASXC.

What is Asensus Surgical, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Aug 22 2024, ASXC's PE ratio (Price to Earnings) is -1.14 and Price to Sales (PS) ratio is 9.69. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ASXC PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Asensus Surgical, Inc.'s stock?

In the past 10 years, Asensus Surgical, Inc. has provided -0.404 (multiply by 100 for percentage) rate of return.